Endoscopic Balloon Therapy

Michael J Klingler; Matthew Kroh

doi:10.1016/j.suc.2020.12.009

Endoscopic Balloon Therapy

Surg Clin North Am. 2021 Apr;101(2):355-371. doi: 10.1016/j.suc.2020.12.009.

Authors

Michael J Klingler¹, Matthew Kroh²

Affiliations

¹ Cleveland Clinic, 9500 Euclid Avenue, Mail Code H18, Cleveland, OH 44195-0001, USA. Electronic address: Klinglm@ccf.org.
² Cleveland Clinic Abu Dhabi, PO Box 112412, Al Maryah Island, Abu Dhabi, United Arab Emirates.

PMID: 33743974
DOI: 10.1016/j.suc.2020.12.009

Abstract

Intragastric balloon therapy is an endoluminal treatment of obesity that is indicated for patients with moderate obesity (body mass index, 30-35 kg/m²) who have failed to lose weight with lifestyle and medical management. Treatment duration ranges from 4 to 12 months, and percent total body weight loss ranges from 6% to 15% at the time of balloon removal. Adverse events, such as bowel obstruction or gastric perforation, are rare, and early balloon removal because of intolerance is the most common complication. Long-term data are lacking, although weight regain after balloon removal seems to be common.

Keywords: Endoluminal bariatrics; Endoscopic bariatrics; Intragastric balloon.

Publication types

Review

MeSH terms

Body Mass Index*
Endoscopy, Gastrointestinal / methods*
Gastric Balloon*
Humans
Obesity, Morbid / physiopathology
Obesity, Morbid / therapy*
Weight Loss / physiology*